Search

everythinglearnresearchcommunity

for

Search:↓

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

SLE and DM can coexist but are rare and need careful evaluation.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Hydroxychloroquine may help COVID-19 patients with lupus.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

A 17-year-old girl with lupus had vocal cord paralysis but improved with treatment.

Hydroxychloroquine may help delay skin damage in lupus patients.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.